TET2 mutations often occur early during the development of human myeloid malignancies, including PV, ET, MF, myelodysplastic syndrome (MDS), chronic myelomonocytic leukemia (CMML), and acute myeloid leukemia (AML). The gene discussed is TET2; the disease is myelodysplastic syndrome.